Healthy volunteers ( N = 20 ) were recruited to receive a 0.05-mL ( 2U ) injection of BoTNA at four forehead sites ( medial forehead ( subcutaneous ( SC ) ) and temporal forehead ( intradermal ( ID ) ) ) .